Wednesday, April 24, 2013

Georges St-Pierre says he still has challenges at 170 lbs

UFC welterweight champion Georges St-Pierre stopped by the "UFC Tonight" studio and talked about the challenges he sees on the horizon. While everyone is clamoring for an Anderson Silva-Georges St-Pierre bout, he thinks there are still plenty of challenges for him to tackle at welterweight. And as he's claimed many times, St-Pierre said a move up to fight Silva at middleweight would have to be a permanent move because he doesn't want to cut back down. GSP also talked about his new book, his week of Hollywood glamor, and the reasoning behind that hair. Check it out.

Source: http://sports.yahoo.com/blogs/mma-cagewriter/georges-st-pierre-says-still-challenges-170-lbs-131440236--mma.html

What is ricin Boston Marathon Explosion Boston Marathon bombing irs new york times Friends Reunion Elena Delle Donne

Uncleaned cells mean weak muscles

Apr. 23, 2013 ? The protein complex mTORC1 promotes muscle growth. However, should this complex remain constantly active, it impairs the ability of the cells to self-clean, causing myopathy. Scientists working with Markus R?egg, Professor at the Biozentrum, University of Basel, describe the exact mechanism involved in the current issue of the scientific journal Cell Metabolism.

Similarly to parts in a machine, individual components of a cell wear out with time. For a cell to remain healthy, malfunctioning components and waste products must be regularly disposed of or recycled. A cellular self-cleaning process, called autophagy, is responsible for this. However, the capacity for self-renewal decreases with age and participates in a wide range of age-related diseases such as cancer, heart disease and muscle weakness. In this process, the growth regulator, mTORC1, plays a primary role. The exact relationship has now been discovered by Markus R?egg's team from the Biozentrum of the University of Basel, together with scientists from the Department of Biomedicine.

Muscle weakness due to overactive growth regulator

Until recently, it was assumed that the protein complex mTORC1 in the skeletal muscle plays a key role in growth regulation but not in the process of autophagy. R?egg and his team of scientists have been able to refute this widely accepted assumption. In the current study, they investigated the cellular processes in skeletal muscle of mice, in which mTORC1 was permanently activated. Particularly in aging mice, the scientists observed a progressive myopathy, which could be ascribed to impaired autophagy. Interestingly, the researchers could reverse the symptoms by administering rapamycin. The muscle function of the mice returned to normal. Rapamycin is a substance that inhibits mTORC1, thereby promoting cell self-cleaning.

Counteracting muscle breakdown

According to these findings, mTORC1 plays a major role in tightly coordinating the mechanism of autophagy, maintaining the balance between muscle growth and breakdown. The scientists suspect that an overactive mTORC1 complex may also contribute to the development of the age-related muscle weakness seen in man. Therefore, a closer examination of the mTORC1 regulation system in the context of aging may provide new therapeutic approaches for the counteracting of the muscle weakness.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Universit?t Basel.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Perrine Castets, Shuo Lin, Nathalie Rion, Sabrina Di?Fulvio, Klaas Romanino, Maitea Guridi, Stephan Frank, Lionel?A. Tintignac, Michael Sinnreich, Markus?A. R?egg. Sustained Activation of mTORC1 in Skeletal Muscle Inhibits Constitutive and Starvation-Induced Autophagy and Causes a Severe, Late-Onset Myopathy. Cell Metabolism, 2013; DOI: 10.1016/j.cmet.2013.03.015

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/R87ZMobNvdQ/130423091028.htm

Alexa Vega Bram Stoker books Paula Broadwell Photos Veterans Day 2012 Nate Silver stock market stock market

Lawyer: Inspectors clear US horse slaughterhouse - Economy news

ROSWELL, New Mexico (AP) ? The attorney for a proposed horse slaughterhouse in southeastern New Mexico says a federal inspection Tuesday went well and the plant hopes to be in business soon.

Attorney Blair Dunn says agriculture officials found no issues at Valley Meat Co. and told the owners Tuesday they are recommending a grant of inspection be issued immediately. Dunn says he expects final approval for the plant to come in a matter of days.

Valley Meat Co. has become ground zero for an emotional, national debate in America over a return to domestic horse slaughter that has divided horse rescue and animal humane groups, ranchers, politicians and Indian tribes.

Fueling opposition is a recent uproar in Europe over horse meat being found in products labeled as beef. The company hopes the inspection ends a yearlong political drama that has left it idle and made owner Rick De Los Santos and his wife, Sarah, targets of vandalism and death threats.

Valley Meat Co. is a former cattle slaughterhouse whose kill floor has been redesigned for horses to be led in one at a time, secured in a huge metal chute, shot in the head, then processed into meat for shipment overseas.

At issue was whether horses are livestock or pets, and whether it is more humane to slaughter them domestically than to ship tens of thousands of neglected, unwanted and wild horses thousands of miles (kilometers) to be slaughtered in Mexico or Canada.

Front and center of the debate is De Los Santos, who along with his wife, has for more than two decades worked this small slaughterhouse, taking in mostly cows that were too old or sick to travel with larger herds to the bigger slaughterhouses for production.

Now, with cattle herds shrinking amid an ongoing drought, De Los Santos says he and his wife are just trying to transform their business and make enough money to retire by slaughtering domestically some of the thousands of horses that he says travel through the state every month on their way to what are oftentimes less humane and less regulated plants south of the border.

"They are being slaughtered anyway. We thought, well, we will slaughter them here and provide jobs for the economy," De Los Santos said. Instead, Valley Meat has been ensnarled in a yearlong political drama that has left the plant idle and its owners the target of vandalism and death threats ? warnings that increased after humane groups found a video a now-former plant worker posted of himself cursing at animal activists, then shooting one of his own horses to eat.

"People are saying, 'We will slit your throat in your sleep. We hope you die. We hope your kids die,'" De Los Santos said. "Sometimes it's scary. ... And it's all for a horse." Indeed, voice mails left on the company's answering machine spew hate and wishes for violence upon the family.

"I hope you burn in hell," said one irate woman who called repeatedly, saying, "You better pack your (expletive) bags (expletive) and get out of there because that place is finished." The couple have hired security and turned over phone records to federal authorities.

"It's complicated, this industry of feeding the world," Sarah De Los Santos says matter-of-factly. The meat would be processed for human consumption and exported to countries in eastern Europe and Asia.

The Obama administration wants to prohibit horse slaughter. The administration's 2014 budget request excludes money for inspectors for horse slaughter plants, which would effectively keep them from operating.

Humane groups and politicians including Gov. Susana Martinez and New Mexico Attorney General Gary King strongly oppose the plant. They argue that horses are iconic animals in the West, and that other solutions and more funding for horse rescue and birth control programs should be explored over slaughter.

Still others are pushing for a return to domestic slaughter. Proponents include several Native American tribes, the American Quarter Horse Association, some livestock associations and even a few horse rescue groups that believe domestic slaughter would be more humane than shipping the animals elsewhere.

Follow Jeri Clausing at https://twitter.com/jericlausing

Share article: Lawyer: Inspectors clear US horse slaughterhouse

Source: http://www.mail.com/int/business/economy/2039896-lawyer-inspectors-clear-us-horse-slaughterhouse.html

brian urlacher kate upton Harry Reems ncaa basketball ncaa tournament schedule March Madness Live Google Keep

CSN: Nats still struggling? |? O's walk-off vs. Jays

Want a quick synopsis of the state of the Nationals' lineup 19 games into the season? Adam LaRoche has the condensed version.

"We're not getting the big hits," the veteran first baseman said. "A lot of quick innings. Not a ton of baserunners. And five or six guys that aren't swinging the bat real good. When it rains, it pours."

The rain may not be at cats-and-dogs stages right now, but it's coming down at a steady rate, resulting in more than a few frustrating losses like Monday's 3-2 defeat at the hands of the Cardinals.

Despite getting the closest thing Dan Haren has offered up to a quality start this season and some sparkling work out of their bullpen, the Nationals couldn't exorcise their St. Louis demons from last October because they couldn't produce a clutch hit late despite several opportunities.

Thus, a Nationals club that three weeks ago was everyone's prohibitive favorite to reach the World Series fell to 10-9. Yes, they're still over .500, but there's something unsettling about the way they've played to date, especially at the plate.

As a team, the Nationals are hitting .240. Individually, three regulars own batting averages below that mark: LaRoche (.185), Danny Espinosa (.176) and the third base duo of Ryan Zimmerman and Anthony Rendon (.213 combined). Throw in three key bench players who have been abysmal so far ? Tyler Moore (.158), Chad Tracy (.136) and Roger Bernadina (0-for-15) ? and it's easy to see why they've had such trouble scoring runs in bunches.

"It think that's what we're kind of stumped on," LaRoche said. "It's normal to have a couple of guys that aren't going. But it gets kind of washed away when you've got other guys picking up the slack. Now we just don't have that. And that can turn into guys pressing. When you have a chance to score, to try a little too hard."

LaRoche and Desmond might well have been guilty of that during a critical juncture in Monday night's game. After watching a potential seventh-inning rally snuffed out when Cardinals center fielder Jon Jay made a nifty, sliding catch of Tracy's broken-bat blooper with two on and two out, the Nationals gave themselves another opportunity in the bottom of the eighth.

Denard Span beat out a grounder to third to get things started, then after Jayson Werth struck out, Bryce Harper drew a walk against St. Louis reliever Trevor Rosenthal. To the plate stepped LaRoche with a chance to drive in the tying run.

Instead, the cleanup hitter bounced Rosenthal's first pitch to first base, advancing the runners but recording the second out of the inning in the process.

"That guy can throw 100," LaRoche said of Rosenthal. "The first fastball you see, you want to go after it. And if you miss it, go after the next one."

With two outs and runners on second and third, Desmond stepped up with his own chance to drive in the tying run, and possibly the go-ahead run as well. But the All-Star shortstop was headed back to the bench in short order, taking a fastball for strike one, swinging out of his shoelaces and missing for strike two, then watching a 98 mph fastball from Rosenthal sail right through the heart of the zone for strike three.

"That's the situation I want to be in: Tying run on second, and the game on the line," Desmond said. "I'll take me in that situation any day of the week. He just got me out in that situation today. Hopefully I get that opportunity again."

Davey Johnson didn't sound entirely pleased with his hitters' approach in those situations.

"All he was throwing was fastballs," the manager said. "The umpire was giving him a little bit of the top end of the strike zone, but you've got to make him bring it down and just center on the fastball."

The Nationals went down quietly in the ninth against recently named Cardinals closer Edward Mujica, ending a frustrating night and leaving Haren to suffer his third loss in four starts despite the fact he showed significant signs of improvement in this one.

After getting beat around by the Reds, White Sox and Marlins, Haren was hoping to at least record his first quality start as a National. He was on track to do just that, entering the sixth inning having allowed only two runs with a manageable pitch count of 87. But the veteran right-hander not only couldn't get through the sixth, he couldn't even record an out.

Haren's undoing began when he plunked Matt Holliday with a pitch, then exacerbated itself on back-to-back singles by Carlos Beltran and Yadier Molina and finally a walk to David Freese. Out to the mound strolled Johnson, asking for the ball from his starter, who wasn't interested in finding the positives out of this latest loss.

"Not really," Haren said. "I want more out of myself than five innings, giving up three runs and [reliever Craig] Stammen bailing me out of that jam. I've been around for 10 years. I'm used to throwing seven, eight innings every time. I've thrown 200 innings many times. Going five innings, you're not going to do that."

It took a major escape act from Stammen ? stranding the bases loaded with nobody out ? to keep the deficit at 3-2 and at least give the Nationals lineup a chance to rally late.

But this lineup hasn't been able to rally much so far this season. And that has left this team in a strange position: Still boasting a winning record but not living up to the lofty expectations placed upon it.

"It's a long season," Desmond said. "As an outsider looking in, you see 98 wins last year and you expect to see the same again this year. But in order to win 98 games, you've got to lose a bunch of games, too. It doesn't matter if we lose them in April or September or October or whatever. We've just got to keep on playing and it'll turn for us."

Source: http://www.csnwashington.com/baseball-washington-nationals/talk/lackluster-lineup-leads-another-nats-loss

duke university whale shark whale shark platypus platypus overboard east of eden

Tuesday, April 23, 2013

Hundreds of potential drug targets to starve cancer tumors identified

Apr. 21, 2013 ? A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer. The analysis, conducted by researchers at Columbia University Medical Center, also identified hundreds of potential drug targets that could cut off a tumor's fuel supply or interfere with its ability to synthesize essential building blocks. The study was published today in the online edition of Nature Biotechnology.

The results should ramp up research into drugs that interfere with cancer metabolism, a field that dominated cancer research in the early 20th century and has recently undergone a renaissance.

"The importance of this new study is its scope," said Dennis Vitkup, PhD, associate professor of biomedical informatics (in the Initiative in Systems Biology) at CUMC, the study's lead investigator. "So far, people have focused mainly on a few genes involved in major metabolic processes. Our study provides a comprehensive, global view of diverse metabolic alterations at the level of gene expression."

Cell metabolism is a dynamic network of reactions inside cells that process nutrients, such as glucose, to obtain energy and synthesize building blocks needed to produce new cellular components. To support uncontrolled proliferation, cancer needs to significantly reprogram and "supercharge" a cell's normal metabolic pathways.

The first researcher to notice cancer's special metabolism was German biochemist Otto Warburg, who in 1924 observed that cancer cells had a peculiar way of utilizing glucose to make energy for the cell. "Although a list of biochemical pathways in normal cells was comprehensively mapped during the last century," said Dr. Vitkup. "We still lack a complete understanding of their usage, regulation, and reprogramming in cancer."

"Right now we have something like a static road map. We know where the streets are, but we don't know how traffic flows through the streets and intersections," said Jie Hu, PhD, a postdoctoral researcher at Columbia and first author of the study. "What researchers need is something similar to Google Traffic, which shows the flow and dynamic changes in car traffic."

Drs. Hu and Vitkup's study is an important step toward achieving this dynamic view of cancer metabolism. Notably, the researchers found that the tumor-induced expression changes are significantly different across diverse tumors. Although some metabolic changes -- such as an increase in nucleotide biosynthesis and glycolysis -- appear to be more frequent across tumors, others, such as changes in oxidation phosphorylation, are heterogeneous.

"Our study clearly demonstrates that there are no single and universal changes in cancer metabolism," said Matthew Vander Heiden, MD, PhD, assistant professor at MIT, and a co-author of the paper. "That means that to understand transformation in cancer metabolism, researchers will need to consider how different tumor types adapt their metabolism to meet their specific needs."

The researchers also found that expression changes can mimic or cooperate with cancer mutations to drive tumor formation. A notable example is the enzyme isocitrate dehydrogenase. In several cancers, such as glioblastoma and acute myeloid leukemia, mutations in this enzyme are known to produce a specific metabolite -- 2-hydroxyglutarate -- that promotes tumor growth. The Columbia team found that isocitrate dehydrogenase expression significantly increases in tumors with the recurrent mutations. Such an overexpression may create an efficient enzymatic factory for overproduction of 2-hydroxyglutarate.

The analysis also led the researchers to an interesting finding in colon cancer. In several other cancers, mutations in two enzymes -- succinate dehydrogenase and fumarate hydratase -- can promote tumor formation as a result of efflux from mitochondria and accumulation of their substrates, fumarate and succinate. The researchers found that in colon cancer, accumulation of these metabolites may be caused by a significant decrease in the enzymes' expression. This was confirmed when metabolomics data from colon tumor patients showed significantly higher concentrations of fumarate in tumors than in normal tissue.

"These are just several examples of how cancer cells use various creative mechanisms to hijack the metabolism of native cells for their own purposes," said Dr. Vitkup.

For cancer researchers looking for new drug targets, Dr. Vitkup's team also found hundreds of differences between normal and cancer cells' use of isoenzymes. This opens up additional possibilities for turning off cancer's fuel and supply lines. Isoenzymes often catalyze the same reactions, but have different kinetic properties: Some act quickly and sustain rapid growth, while others are more sluggish. In kidney and liver cancers, for example, a quick-acting aldolase isoenzyme -- suitable for fast cell proliferation -- was found to be more prevalent than the more typical slow-moving version found in normal kidney and liver tissue. Although a few examples of differential isoenzyme expression in tumors were already known, the Columbia researchers identified hundreds of isoenzymes with cancer-specific expression patterns.

"Inhibiting specific isoenzymes in tumors may be a way to selectively hit cancer cells without affecting normal cells, which could get by with other isoenzymes," said Dr. Hu.

In fact, a recent study from Matthew Vander Heiden's laboratory demonstrated the potential of targeting a specific isoenzyme, pyruvate kinase M2, expression of which often increases in tumors. "The comprehensive expression analysis suggests that a similar approach could potentially be applied in multiple other cases," said Dr. Vander Heiden.

Targeting metabolism may be a way to strike cancer at its roots. "Cancer cells usually have multiple ways to turn on their growth program," said Dr. Vitkup. "You can knock out one, but the cells will usually find another pathway to turn on proliferation. Targeting metabolism may be more powerful, because if you starve a cell of energy or materials, it has nowhere to go."

The paper is titled, "Heterogeneity of tumor-induced gene expression changes in the human metabolic network." The other authors are Jason W. Locasale (Cornell University), Jason H. Bielas (Fred Hutchinson Cancer Research Center, Seattle, Wash.; and University of Washington, Seattle, Wash.), Jacintha O'Sullivan (St. Vincent's University Hospital, Dublin, Ireland), Kieran Sheahan St. Vincent's University Hospital, Dublin, Ireland), and Lewis C. Cantley (Harvard Medical School).

Dr. Vander Heiden is a consultant and advisory board member, and Dr. Cantley is a consultant and founder, of Agios Pharmaceuticals. The authors report no other financial or potential conflicts of interest.

This work was supported by National Institutes of Health grant GM079759 to Dr. Vitkup and National Centers for Biomedical Computing grant U54CA121852 to Columbia University. Dr. Locasale is supported by an NIH Pathway to Independence Award R00CA168997. Dr. Bielas is supported by an Ellison Medical Foundation New Scholar award AG-NS-0577-09, a National Institute of Environmental Health Sciences grant R01ES019319, and New Development Funds from the Fred Hutchinson Cancer Research Center. Dr. Vander Heiden acknowledges support from the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, the Smith Family, and the National Cancer Institute.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:


Story Source:

The above story is reprinted from materials provided by Columbia University Medical Center.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Jie Hu, Jason W Locasale, Jason H Bielas, Jacintha O'Sullivan, Kieran Sheahan, Lewis C Cantley, Matthew G Vander Heiden, Dennis Vitkup. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nature Biotechnology, 2013; DOI: 10.1038/nbt.2530

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/~3/NxLu-Y1ENBQ/130421151616.htm

million hoodie march tebow trade mike the situation jacksonville jaguars jacksonville jaguars benjarvus green ellis shaka smart

Does international child sponsorship work? New research says yes

Does international child sponsorship work? New research says yes [ Back to EurekAlert! ] Public release date: 22-Apr-2013
[ | E-mail | Share Share ]

Contact: Adam Gannaway
agannaway@press.uchicago.edu
773-702-2037
University of Chicago Press Journals

Child sponsorship is a leading form of direct aid from households in wealthy countries to children in developing countries, with approximately 3.39 billion dollars spent to sponsor 9.14 million children internationally. A new study to be published in the Journal of Political Economy shows international child sponsorship to result in markedly higher rates of schooling completion and substantially improved adult employment outcomes.

Researchers used first-hand survey data from a study of Compassion International, a leading child sponsorship organization, to examine the adult life outcomes of a group of 10,144 individuals in Bolivia, Guatemala, India, Kenya, the Philippines, and Uganda that included children who began sponsorship through the program a generation ago. The study estimates causal effects on adult life outcomes in areas such as educational completion, type of employment, and community leadership.

Specifically, the study finds that international sponsorship increased the probability of a child completing secondary school by 27%, completing a university education by 50%, and obtaining a white-collar job as an adult by about 35%.

Despite the billions of dollars that flow to child sponsorship each year and the millions of American families who sponsor overseas children, this is the first published study to investigate whether such programs actually benefit the children they intend to help. Evidence from the study points to the positive effects of child sponsorship on the adult life outcomes of these children.

Compassion's program places a strong emphasis not only on providing for the basic needs, such as school tuition and healthcare, but also on nurturing children's life aspirations and self-esteem over what is typically a decade of participation in sponsorship programs. "Too often we have focused our development efforts on provision for human beings rather than the development of human beings," said Bruce Wydick, one of the study's authors. "Although child sponsorship does indeed provide help with school fees, access to health care, and other tangible benefits, Compassion's particular approach focuses on the more holistic development of the child, such as development of self-esteem, aspirations, spiritual and ethical values. In follow-up studies involving currently sponsored children, we measure very large impacts in these areas, which we believe play a significant role in what we observe in the difference in adult life outcomes."

While further research is needed to establish a causal link between aspirations and adult life outcomes, this study has intriguing implications for the way we view economic development. Said Wydick, "I believe our research contributes to a new and growing body of investigation that seeks to examine the importance of 'internal constraints' to economic developmentthe importance of aspirations, self-esteem, goals, and reference points related to behaviors that are propitious to helping the poor escape poverty."

###

Bruce Wydick, Paul Glewwe, and Laine Rutledge, "Does International Child Sponsorship Work? A Six-Country Study of Impacts on Adult Life Outcomes." Journal of Political Economy 121:2 (published April 2013).

One of the oldest and most prestigious journals in economics, the Journal of Political Economy (journals.uchicago.edu/JPE) has since 1892 presented significant research and scholarship in economic theory and practice. The journal aims to publish highly selective, widely cited articles of current relevance that will have a long-term impact on economics research.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Does international child sponsorship work? New research says yes [ Back to EurekAlert! ] Public release date: 22-Apr-2013
[ | E-mail | Share Share ]

Contact: Adam Gannaway
agannaway@press.uchicago.edu
773-702-2037
University of Chicago Press Journals

Child sponsorship is a leading form of direct aid from households in wealthy countries to children in developing countries, with approximately 3.39 billion dollars spent to sponsor 9.14 million children internationally. A new study to be published in the Journal of Political Economy shows international child sponsorship to result in markedly higher rates of schooling completion and substantially improved adult employment outcomes.

Researchers used first-hand survey data from a study of Compassion International, a leading child sponsorship organization, to examine the adult life outcomes of a group of 10,144 individuals in Bolivia, Guatemala, India, Kenya, the Philippines, and Uganda that included children who began sponsorship through the program a generation ago. The study estimates causal effects on adult life outcomes in areas such as educational completion, type of employment, and community leadership.

Specifically, the study finds that international sponsorship increased the probability of a child completing secondary school by 27%, completing a university education by 50%, and obtaining a white-collar job as an adult by about 35%.

Despite the billions of dollars that flow to child sponsorship each year and the millions of American families who sponsor overseas children, this is the first published study to investigate whether such programs actually benefit the children they intend to help. Evidence from the study points to the positive effects of child sponsorship on the adult life outcomes of these children.

Compassion's program places a strong emphasis not only on providing for the basic needs, such as school tuition and healthcare, but also on nurturing children's life aspirations and self-esteem over what is typically a decade of participation in sponsorship programs. "Too often we have focused our development efforts on provision for human beings rather than the development of human beings," said Bruce Wydick, one of the study's authors. "Although child sponsorship does indeed provide help with school fees, access to health care, and other tangible benefits, Compassion's particular approach focuses on the more holistic development of the child, such as development of self-esteem, aspirations, spiritual and ethical values. In follow-up studies involving currently sponsored children, we measure very large impacts in these areas, which we believe play a significant role in what we observe in the difference in adult life outcomes."

While further research is needed to establish a causal link between aspirations and adult life outcomes, this study has intriguing implications for the way we view economic development. Said Wydick, "I believe our research contributes to a new and growing body of investigation that seeks to examine the importance of 'internal constraints' to economic developmentthe importance of aspirations, self-esteem, goals, and reference points related to behaviors that are propitious to helping the poor escape poverty."

###

Bruce Wydick, Paul Glewwe, and Laine Rutledge, "Does International Child Sponsorship Work? A Six-Country Study of Impacts on Adult Life Outcomes." Journal of Political Economy 121:2 (published April 2013).

One of the oldest and most prestigious journals in economics, the Journal of Political Economy (journals.uchicago.edu/JPE) has since 1892 presented significant research and scholarship in economic theory and practice. The journal aims to publish highly selective, widely cited articles of current relevance that will have a long-term impact on economics research.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-04/uocp-dic042213.php

OJ Murdock Olympics Live Mens Gymnastics Allison Schmitt Olympic Schedule Kyla Ross Montenegro

Box Office Guru Wrapup: Oblivion Easily Takes Top Spot in Debut

Now in his fourth decade of scoring number one hit movies, Tom Cruise enjoyed one of the best openings of his entire career with the futuristic science fiction film Oblivion which topped the box office worldwide. Universal saw its latest hit film open to an estimated $38.2M in North America from 3,783 theaters for a potent $10,085 average. 323 IMAX sites contributed a solid $5.5M, or 14% of the gross.

That was an impressive performance for an original 2D sci-fi film opening outside of summer. In fact, it was the second best sci-fi opening ever during the month of April after the $61.2M of 2010's 3D remake Clash of the Titans. Overall, it was the seventh best for the month but third biggest for a live-action non-sequel.

Directed by Joseph Kosinski (TRON: Legacy) and co-starring Morgan Freeman, Oblivion earned mixed reviews from critics, however paying audiences were not pleased. The CinemaScore grade was a disappointing B- indicating a rocky road ahead. Adult men made up the core audience - not surprising for a sci-fi film and for a Cruise actioner as the actor has lost some of his female fan base in recent years. Studio research showed that 57% of the audience was male and a very high 74% was 25 or older. Teen appeal was minimal here.

But for Cruise, Oblivion delivered the second biggest opening of his career outside of his signature Mission: Impossible franchise trailing just one other science fiction picture -- 2005's summer smash War of the Worlds from Steven Spielberg, which bowed to a holiday-boosted $64.9M. And it more than doubled the $15.2M debut of the actor's last film Jack Reacher from this last December.

Produced for a reported $120M, Oblivion is just one of many big-budget apocalyptic movies from some of Hollywood's hottest male action stars that will compete for the public's attention over the coming months. Next up, Will Smith stars in After Earth opening May 31, then Brad Pitt offers up World War Z in June, followed in August by Matt Damon's Elysium. The end of humanity is also a topic in the raunchy comedy This Is The End with Seth Rogen and James Franco arriving in June.

Made for a global audience, Oblivion pulled in a healthy $33.7M from 60 international markets this weekend dropping 42% from its overseas launch last week. The offshore take now stands at $112M with the global gross at $150.2M on its way to much more as major markets like Japan and China have yet to open.

After a spectacular opening weekend, the baseball drama 42 held up well in its second frame dipping 34% to an estimated $18M for a ten-day total of $54.1M. Warner Bros. should find its way across the $100M mark with this one. Breaking the $150M mark this weekend was the hit animated comedy The Croods, which continued to take advantage of no competition for kids with an estimated $9.5M in its fifth round. Off just 28%, the Fox release had the lowest decline of any film in the top ten and boosted its domestic cume to $154.9M. With $23.4M from offshore markets this weekend, the international total soared to $274.5M, putting The Croods at $429.4M worldwide.

The sequel flop Scary Movie 5 tumbled 56% in its sophomore frame to an estimated $6.3M giving The Weinstein Co. $22.9M after ten days. A final gross of $30-35M seems likely which would be about one-third of the $90.7M that part 4 in the franchise did seven years ago.

The action sequel G.I. Joe: Retaliation followed in fifth with an estimated $5.8M, down 47%, for a $111.2M total for Paramount. Overseas action got a boost from a gigantic opening week in China where the American soldiers took in $33M from 7,000 screens over seven days including over $3M from 101 IMAX sites. That drove the international weekend to $40M, the overseas cume to $211.7M, and the global tally to a muscular $322.9M. With Japan yet to open, Joe could find its way to nearly $450M worldwide -- 50% more than the first movie in the franchise.

The Ryan Gosling pic The Place Beyond The Pines tripled its theater count and jumped from tenth to sixth place but saw its average drop down to a soft amount. The Focus release grossed an estimated $4.7M from 1,542 locations for a weak $3,078 average and $11.4M total.

Still on its way into the century club, the action hit Olympus Has Fallen placed seventh dropping 38% to an estimated $4.5M putting the year's first of two White-House-under-attack flicks at an impressive $88.8M for FilmDistrict. Sony's horror remake Evil Dead fell 57% to an estimated $4.1M and has scared up $48.4M to date.

Close behind with an estimated $4M was the 3D re-release of Jurassic Park which declined by 55% for a cume of $38.5M. The Universal blockbuster's lifetime gross has now shot up to $395.6M. Rounding out the top ten was 2013's biggest hit, Oz the Great and Powerful. The Disney smash held up well with an estimated $3M in its seventh weekend, off 37%. The wizard and trio of witches have now amassed $223.8M from North america and a stellar $478.6M worldwide.

The top ten films grossed an estimated $98.1M which was down 18% from last year when Think Like A Man opened at number one with $33.6M; and down 14% from 2011 when Rio stayed in the top spot with $26.3M.

Follow Gitesh on Twitter!

Source: http://www.rottentomatoes.com/m/1927299/news/1927299/

denver broncos new england patriots Zayn Malik miss america 2013 Oscar Nominations ABC Family social security